| Literature DB >> 35221608 |
Aderajew Nigusse Tekelehaimanot1, Tefera Belachew1, Esayas Kebede Gudina2, Masrie Getnet3, Demuma Amdisa4, Lelisa Sena Dadi3.
Abstract
BACKGROUND: Ethiopia has been motivated to achieve a goal of "appointment spacing model approach care." However, little has been documented on the predictor of mortality and challenges of sustainable HIV care. Therefore, the aim of this study was to determine predictors of mortality among adult people living with HIV/AIDS on antiretroviral therapy (ART).Entities:
Keywords: ART; Adult; Appointment Spacing Modals; Jimma zone; PLWHA; Predictors
Mesh:
Substances:
Year: 2021 PMID: 35221608 PMCID: PMC8843146 DOI: 10.4314/ejhs.v31i5.3
Source DB: PubMed Journal: Ethiop J Health Sci ISSN: 1029-1857
Socio-demographic characteristic of adult PLWHA in public hospitals, September 2012 – August 2016
| Variables | Classification | Number | Percent |
| Sex | Male | 294 | 43.4 |
| Female | 382 | 56.5 | |
| Age group | 18–24 | 97 | 14.3 |
| 25–34 | 244 | 36.1 | |
| 35–44 | 243 | 35.9 | |
| 45–54 | 72 | 10.6 | |
| >55 | 20 | 2.9 | |
| Marital status | Single | 92 | 13.6 |
| Married | 376 | 55.6 | |
| Divorced | 132 | 19.5 | |
| Widowed | 77 | 11.3 | |
| Level of Education | Illiterate | 140 | 20.7 |
| Primary | 271 | 40.1 | |
| Secondary | 190 | 28.1 | |
| Collage | 75 | 11.1 | |
| Residence | Urban | 412 | 60.9 |
| Rural | 264 | 39.1 | |
| Catchment area | within catchment | 548 | 81.1 |
| out of catchment | 128 | 18.9 | |
| Have Care giver | Yes | 448 | 66.3 |
| No | 228 | 33.7 | |
| Disclosure | Yes | 467 | 68.9 |
| No | 211 | 31.1 | |
| History using alcohol | Yes | 397 | 58.6 |
| No | 281 | 41.4 | |
| History of | |||
| Yes | 540 | 79.6 | |
| No | 138 | 20.4 |
Figure 1Opportunistic infection among adult PLWHA on ART, Jimma Zone public hospitals, September 2012 – August 2016.
Overall life table of PLWHA on ART follow up in Jimma Zone public hospitals southwest Ethiopia, September 2012 – August 2016
| Interval | Beginning | Death/98 | Lost/134 | Survival | Sta/ error | 95% CI | |
| 0–6 | 676 | 10 | 0 | 0.9783 | 0.0042 | 0.9766 | 0.9941 |
| 6–12 | 666 | 5 | 0 | 0.8781 | 0.0056 | 0.9639 | 0.9867 |
| 12–18 | 661 | 8 | 34 | 0.9325 | 0.0091 | 0.9209 | 0.9570 |
| 18–24 | 608 | 19 | 13 | 0.9211 | 0.0106 | 0.8965 | 0.9386 |
| 24–30 | 558 | 14 | 12 | 0.9022 | 0.0118 | 0.8763 | 0.9230 |
| 30–36 | 561 | 17 | 23 | 0.8853 | 0.0129 | 0.8582 | 0.9091 |
| 36–42 | 521 | 9 | 25 | 0.8748 | 0.0137 | 0.8451 | 0.8992 |
| 42–48 | 487 | 11 | 16 | 0.8608 | 0.0158 | 0.7289 | 0.8874 |
| 48–54 | 476 | 1 | 10 | 0.8500 | 0.0159 | 0.8157 | 0.8782 |
| 54–60 | 470 | 4 | 2 | 0.8453 | 0.0565 | 0.7096 | 0.9748 |
Figure 2Kaplan Meier survival curve of PLWHA on ART follows up Jimma zone public hospitals by baseline WHO stages September 2012 – August 2016.
Predictors of mortality among Adult PLWHA in Jimma Zone public hospitals, Southwest Ethiopia, 2012 – August 2016
| Variables | Classification | Death | Censored | CHR (95%) | AHR (95%) | P |
| Age group | 18–24 | 40(40.8) | 57(9.8) | 4.1 (1.5,11.3) | 2.1 (1.7, 3.3) | 0.01 |
| 25–34 | 23(23.5) | 221(38.2) | 2.3 (1.8, 6.6) | 0.8(0.3, 2.4) | 0.04 | |
| 35–44 | 10(10.2) | 232(40.1) | 1 | 1 | ||
| 45–54 | 8(8.2) | 64(11.1) | 2.1 (1.4,16.3) | 0.9 (0.4, 9.3) | 0.38 | |
| >55 | 17(17.3) | 4(0.7) | 3.7 (0.8, 6.6) | 1.8 (0.8, 7.6) | 0.02 | |
| Sex | Male | 34(34.7) | 260(44.9) | 1 | 1 | |
| Female | 64(65.3) | 318(55.0) | 3.1(1.5, 5.5) | 2.8 (2.1,4.6) | 0.03 | |
| Marital status | Married | 9 (9.2) | 36(6.2) | 1 | 1 | |
| Single | 56(57.1) | 367(63.5) | 4.3(2.0, 7.9) | 2.6 (1.8, 3.8) | 0.01 | |
| Divorced | 14 (14.3) | 118(20.4) | 4.1(2.2, 7.2) | 2.4 (1.3, 3.9) | 0.02 | |
| Widowed | 19 (19.4) | 58(10.0) | 3.6 (2.5, 6.7) | 2.3 (1.7, 3.7) | 0.03 | |
| Education Level | Illiterate | 53(54.1) | 87(15.1) | 5.7(3.3,9.8) | 2.5 (1.9, 4.8) | 0.00 |
| Primary(1–8) | 26 (26.5) | 242(41.9) | 2.5(1.6, 6.7) | 2.1 (1.8, 3.6) | 0.01 | |
| Secondary(9–12) | 15 (15.3) | 24(4.2) | 1.5 (1.1, 5.3) | 0.5 (0.3, 3.6) | 0.21 | |
| college | 4(4.1) | 71(12.3) | 1 | 1 | ||
| BMI at initiation of | Normal | 6 (6.1) | 240(41.5) | 1 | 1 | |
| Moderate | 31(3.1) | 298(51.6) | 3.6 (2.3,9.4) | 2.5(1.7, 7.5) | 0.01 | |
| Severe malnutrition | 61(6.1) | 40(6.9) | 5.6 (4.3,8.3) | 3.7 (1.6, 6.7) | 0.01 | |
| Functional status | Working | 29 (29.6) | 372(64.4) | 1 | 1 | |
| Ambulatory | 37 (37.8) | 189(32.7) | 1.3 (1.9, 3.6) | 1.04(0.9, | 0.04 | |
| Bedridden | 32 (32.6) | 17 (2.9) | 6.1 (4.7,18.6) | 3.7(2.4,13.8) | 0.03 | |
| TB-co infection | No TB | 19 (19.4) | 224(38.8) | 1 | 1 | |
| INH Prophylaxis | 21 (21.4) | 172 (29.8) | 1.2 (0.8, 3.1) | 1.1(0.7, | 0.04 | |
| TB treatment | 58 (59.2) | 182(31.5) | 4.5 (3.5, 7.8) | 2.9(1.5, 5.5) | 0.02 | |
| WHO clinical stage | Stage I&II | 8(8.2) | 394(68.2) | 1 | 1 | |
| Stage III | 58 (59.2) | 177(30.6) | 3.5(2.1, 5.4) | 1.7 (1.4, 3.2) | 0.01 | |
| Stage IV | 32 (32.6) | 7 (1.2) | 7.1(3.8, 11.8) | 3.7 (1.7, 5.3) | 0.00 | |
| CD4 count | <200 | 57 (58.2) | 301 (52.1) | 4.2 (1.5,10.3) | 2.3(1.8, 6.3) | 0.01 |
| 201–350 | 28 (28.6) | 221 (38.2) | 2.3 (0.8, 6.6) | 1.7(0.6, 4.9) | 0.02 | |
| >350 | 13 (13.2) | 56 (9.7) | 1.60(1.04, 2.) | 1 | ||
| follow up within | yes | 19 (19.4) | 524(90.7) | 1 | 1 | |
| No | 79(80.6) | 54(9.3) | 6.9 (3.9, 9.2) | 3.6 (1.5, 5.4) | 0.01 | |
| Residence | Urban | 24 (24.4) | 338(58.5) | 4.10(1.5,11.3) | 1 | |
| Rural | 74 (75.6) | 240(41.5) | 2.3 (0.8, 6.6) | 2.1(1.4, 3.3) | 0.02 | |
| Alcohol and Kchat use | Yes | 68(69.4) | 329(56.9) | 3.6 (1.1,2.6) | 1.8 (1.4, 5.4) | 0.03 |
| No | 30(30.6) | 249(43.1) | 1 | 1 | ||
| Patient Status | Not Known | 12 (12.2) | 156(26.9) | 1 | 1 | |
| Clinical failure | 36 (36.7) | 142(24.6) | 4.1 (1.5,10.3) | 2.1 (1.4, 2.8) | 0.02 | |
| Immunologic | 24 (24.5) | 127(21.9) | 2.4(0.7, 5.6) | 1.7 (1.3, 2.7) | 0.02 | |
| Virologic Failure | 26 (26.5) | 153(26.5) | 2.8(1.3,3.7) | 1.7 (1.3, 2.3) | 0.02 | |
| Liver Function test | Normal (0–50) | 29(29.5) | 299(51.2) | 1 | 1 | |
| Abnormal (>50) | 69(70.4) | 284(49.1) | 6.4(3.8, 7.4) | 4.1(2.4, 6.7) | 0.01 |
N.B: HR, hazard ratio; CI, confidence interval; ART, antiretroviral therapy; WHO, World Health Organization; BMI, body mass index